Open to VA participants only
Feb 25, 2026
Cost-Effectiveness of Dapagliflozin in Non-Diabetic Chronic Kidney Disease: A Cost-Effectiveness Analysis Case Study
Marika Cusick, Ph.D., M.S.
HERC helps VA researchers determine the cost of VA care, assess cost-effectiveness, and evaluate the efficiency of VA programs and providers. More »